Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Gillian Gresham

Status

Completed

Conditions

Glioblastoma

Breast Cancer

Uterine Cancer

Melanoma

Loneliness

Pancreas Cancer

Lung Cancer

Cancer

Anxiety

Leukemia

Social Isolation

Cancer Metastatic

Multiple Myeloma

Bladder Cancer

Sarcoma

Neoplasms

Gynecologic Cancer

Kidney Cancer

Lymphoma

Head and Neck Cancer

Prostate Cancer

Stress

Colorectal Cancer

Treatments

Behavioral: Elly Mobile Phone Application

Study type

Interventional

Funder types

Other

Identifiers

NCT04604158

IIT2020-13-GRESHAM-ELLY

Details and patient eligibility

About

This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosis of cancer of any type and currently receiving cancer-targeted treatment or have received cancer-targeted treatment within 6 months of consent date based on self-report. Cancer-targeted treatment includes chemotherapy, radiation therapy, hormonal therapy, biologic therapy, immunotherapy, and surgery.
18 years or older
Access to and ability to use an iPhone (SE+, iOS 12.4+)
Ability to understand and read English
Have an understanding, ability, and willingness to fully comply with study procedures and restrictions

Exclusion criteria

Hearing loss or vision impairment that would preclude the participant from accessing and using the app (use of hearing aids or visual aids is acceptable) based on self-report.